======= SHOC2 ======= == Gene Information == * **Official Symbol**: SHOC2 * **Official Name**: SHOC2 leucine rich repeat scaffold protein * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8036|8036]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9UQ13|Q9UQ13]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SHOC2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SHOC2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602775|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a protein that consists almost entirely of leucine-rich repeats, a domain implicated in protein-protein interactions. The protein may function as a scaffold linking RAS to downstream signal transducers in the RAS/ERK MAP kinase signaling cascade. Mutations in this gene have been associated with Noonan-like syndrome with loose anagen hair. [provided by RefSeq, May 2010]. * **UniProt Summary**: Regulatory subunit of protein phosphatase 1 (PP1c) that acts as a M-Ras/MRAS effector and participates in MAPK pathway activation. Upon M-Ras/MRAS activation, targets PP1c to specifically dephosphorylate the 'Ser-259' inhibitory site of RAF1 kinase and stimulate RAF1 activity at specialized signaling complexes. {ECO:0000269|PubMed:10783161, ECO:0000269|PubMed:16630891, ECO:0000269|PubMed:25137548}. |LRR 4| |protein phosphatase type 1 complex| |photoreceptor outer segment membrane| |protein phosphatase 1 binding| |protein phosphatase regulator activity| |photoreceptor inner segment| |protein serine/threonine phosphatase activity| |positive regulation of Ras protein signal transduction| |positive regulation of small GTPase mediated signal transduction| |fibroblast growth factor receptor signaling pathway| |protein phosphatase binding| |cellular response to fibroblast growth factor stimulus| |response to fibroblast growth factor| |regulation of phosphoprotein phosphatase activity| |regulation of protein dephosphorylation| |regulation of phosphatase activity| |regulation of dephosphorylation| |protein dephosphorylation| |regulation of Ras protein signal transduction| |Ras protein signal transduction| |dephosphorylation| |small GTPase mediated signal transduction| |regulation of small GTPase mediated signal transduction| |cellular response to growth factor stimulus| |transmembrane receptor protein tyrosine kinase signaling pathway| |response to growth factor| |enzyme linked receptor protein signaling pathway| |positive regulation of intracellular signal transduction| |cellular response to endogenous stimulus| |regulation of hydrolase activity| |response to endogenous stimulus| |positive regulation of signal transduction| |intracellular signal transduction| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |regulation of protein modification process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp5|Alpha-Amanitin 0.5μM R00 exp5]]|-3.13| |[[:results:exp351|Dexamethasone 0.006μM R07 exp351]]|-2.86| |[[:results:exp352|Dexamethasone 0.006 to 0.015μM on day4 R07 exp352]]|-2.52| |[[:results:exp470|Chloroquine 32μM R08 exp470]]|-2.51| |[[:results:exp277|Curcumin 6.5μM R06 exp277]]|-2.39| |[[:results:exp436|Dynasore 7μM R08 exp436]]|-2.39| |[[:results:exp23|Nocodazole 0.02μM R00 exp23]]|-2.38| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|-2.33| |[[:results:exp467|CAY10603 0.55μM R08 exp467]]|-2.32| |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|-2.31| |[[:results:exp38|Wortmannin 5μM R00 exp38]]|-2.26| |[[:results:exp485|GSK626616 14μM R08 exp485]]|-2.24| |[[:results:exp301|VER-155008 3.9μM R06 exp301]]|-2.24| |[[:results:exp50|Nicotinamide 2000μM R01 exp50]]|-2.15| |[[:results:exp37|Wortmannin 0.5μM R00 exp37]]|-2.15| |[[:results:exp229|Dimethyloxaloylglycine 100μM R05 exp229]]|-2.08| |[[:results:exp191|Hypoxia 5%O2 R04 exp191]]|-2.06| |[[:results:exp506|Momordin-Ic 10μM R08 exp506]]|-2.02| |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|-2.01| |[[:results:exp510|Nicotine 3000μM R08 exp510]]|-1.99| |[[:results:exp508|NN-Dimethylsphingosine 2.5μM R08 exp508]]|-1.98| |[[:results:exp365|I-BRD9 4μM R07 exp365]]|-1.98| |[[:results:exp27|Pimelic-diphenylamide-106 0.5μM R00 exp27]]|-1.93| |[[:results:exp46|HMS-I1 1μM R01 exp46]]|-1.92| |[[:results:exp169|BH1 1μM R04 exp169]]|-1.91| |[[:results:exp435|JQ1 0.8μM R08 exp435]]|-1.91| |[[:results:exp498|Lead acetate 2000μM R08 exp498 no dilution day6]]|-1.88| |[[:results:exp490|Hydroxychloroquine 30μM R08 exp490]]|-1.84| |[[:results:exp231|Epothilone-B 0.0015μM R05 exp231]]|-1.82| |[[:results:exp462|Cadmium 60μM R08 exp462]]|-1.8| |[[:results:exp29|Rapamycin 1μM R00 exp29]]|-1.8| |[[:results:exp452|Azithromycin 100μM R08 exp452]]|-1.78| |[[:results:exp180|Dynasore 10μM R04 exp180]]|-1.77| |[[:results:exp239|PFI-2 4μM R05 exp239]]|-1.77| |[[:results:exp333|All-trans-Retinoic-Acid 8μM R07 exp333]]|-1.76| |[[:results:exp463|Caffeine 2600μM R08 exp463]]|-1.75| |[[:results:exp31|Rifampicin 1μM R00 exp31]]|-1.74| |[[:results:exp164|Q15 1 to 2μM on day4 R04 exp164]]|-1.73| |[[:results:exp219|A-395N 10μM R05 exp219]]|-1.72| |[[:results:exp471|Cholesterol 0.003 to 0.006 to 0.1μM on day2 then day6 R08 exp471]]|-1.72| |[[:results:exp310|2-Methoxyestradiol 0.55μM R07 exp310]]|-1.7| |[[:results:exp446|4-Nitroquinoline-1-oxide 0.5μM R08 exp446]]|-1.7| |[[:results:exp14|Cycloheximide 0.02μM R00 exp14]]|-1.7| |[[:results:exp236|GSK2606414 1μM R05 exp236]]|-1.7| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|1.7| |[[:results:exp93|DABN racemic mixture R03 exp93]]|1.83| |[[:results:exp126|GSK461364A 0.1μM R03 exp126]]|2.02| |[[:results:exp248|UM0131023 0.05μM R05 exp248]]|2.43| |[[:results:exp514|Phorbol-12-myristate-13-acetate 0.57μM R08 exp514]]|4.88| ^Gene^Correlation^ |[[:human genes:n:nras|NRAS]]|0.609| |[[:human genes:r:raf1|RAF1]]|0.517| |[[:human genes:p:prkce|PRKCE]]|0.492| |[[:human genes:r:rnmt|RNMT]]|0.478| |[[:human genes:r:rce1|RCE1]]|0.475| |[[:human genes:c:cmtr1|CMTR1]]|0.453| |[[:human genes:m:mapk1|MAPK1]]|0.445| |[[:human genes:s:scrib|SCRIB]]|0.444| |[[:human genes:h:hmgb2|HMGB2]]|0.437| |[[:human genes:x:xpot|XPOT]]|0.437| |[[:human genes:b:braf|BRAF]]|0.417| |[[:human genes:e:erg|ERG]]|0.409| |[[:human genes:z:zfx|ZFX]]|0.407| |[[:human genes:x:xpo6|XPO6]]|0.406| |[[:human genes:p:pias4|PIAS4]]|0.404| |[[:human genes:o:osgep|OSGEP]]|0.4| Global Fraction of Cell Lines Where Essential: 7/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|2/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|2/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|1/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 6522 * **Expression level (log2 read counts)**: 5.98 {{:chemogenomics:nalm6 dist.png?nolink |}}